Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lonidamine for Symptomatic Benign Prostatic Hyperplasia
2005-001073-94Phase 3Completed
- Sponsor
- Threshold Pharmaceuticals
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lonidamine in benign prostatic hyperplasia (BPH), sponsored by Threshold Pharmaceuticals. Started Aug 2005; status: completed.
02
Drugs
lonidamine
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on 2005-001073-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001073-94.